Clinical Trials Logo

Clinical Trial Summary

Myotonic dystrophy type 1 (DM1) is one of the most common neuromuscular diseases in adults. As respiratory dysfunction is the most common cause of death in patients with DM1, a respiratory disease progression must be monitored combining symptom screening and respiratory function testing, in order to identify the appropriate time to initiate non invasive ventilation (NIV). Dyspnea, one of the main respiratory symptoms, has been little studied in patients with DM1. The main objective of this study is to provide the first multidimensional description of dyspnea in patients with DM1. The secondary objectives are: - To compare respiratory symptoms according to the presence or not of criteria from respiratory function testing to initiate NIV - To assess associations between dyspnea and respiratory function testing - To assess associations between dyspnea and number of Cytosine Thymine Guanine (CTG) repeats - To assess associations between dyspnea and muscular strength - To assess associations between dyspnea and BMI - To assess associations between dyspnea and anxiety or depression - To assess associations between dyspnea and cognitive impairment - To assess associations between dyspnea and quality of life.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04835298
Study type Observational
Source CHU de Reims
Contact
Status Completed
Phase
Start date July 3, 2020
Completion date June 14, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05481879 - Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 Phase 1/Phase 2
Completed NCT05027269 - Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients Phase 1/Phase 2
Recruiting NCT06411288 - Global Study of Del-desiran for the Treatment of DM1 Phase 3
Completed NCT03589677 - Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life
Completed NCT05560438 - Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1 N/A
Recruiting NCT06185764 - A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) Phase 1/Phase 2
Recruiting NCT05072288 - A Remote Physical Activity Program in the Population Suffering From Type 1 Myotonic Dystrophy N/A
Completed NCT04907162 - Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders